|
21 |
Tissue and systemic inflammation in dystrophic epidermolysis bullosa: a systematic review and meta-analysis
Karakioulaki, Meropi. - Freiburg : Universität, 2025
|
|
|
|
22 |
Topographical variations in the skin barrier and their role in disease pathogenesis
Dajnoki, Zsolt. - Freiburg : Universität, 2025
|
|
|
|
23 |
Tyrosine kinase 2 inhibition improves clinical and molecular hallmarks in various subtypes of cutaneous lupus
Wasserer, Sophia. - Freiburg : Universität, 2025
|
|
|
|
24 |
A disease modifying treatment for psoriasis - anti-Interleukin-23 preferentially inhibits pathogenic T helper 17 cells
Ranzinger, David Lukas. - München : Universitätsbibliothek der TU München, 2024
|
|
|
|
25 |
An international Delphi consensus to define a clinically appropriate definition of disease modification for plaque psoriasis
Eyerich, Kilian. - Freiburg : Universität, 2024
|
|
|
|
26 |
Association of disease duration and PASI response rates at week 12 in patients with moderate-to-severe plaque psoriasis receiving biologics in the real-world psoriasis study of health outcomes (PSoHO)
Pinter, Andreas. - Freiburg : Universität, 2024
|
|
|
|
27 |
Baricitinib treatment rapidly improves the four signs of atopic dermatitis assessed by Eczema Area and Severity Index (EASI) clinical subscores
Wollenberg, Andreas. - Freiburg : Universität, 2023
|
|
|
|
28 |
Characterization of high and low IFNG-expressing subgroups in atopic dermatitis
Wasserer, Sophia. - Freiburg : Universität, 2024
|
|
|
|
29 |
Does regression of skin thickening predict improvement of internal organ involvement and survival in patients with diffuse cutaneous systemic sclerosis? A EUSTAR analysis
Wyss, Anja. - Freiburg : Universität, 2025
|
|
|
|
30 |
Effect of abrocitinib on skin biomarkers in patients with moderate‐to‐severe atopic dermatitis
Guttman‐Yassky, Emma. - Freiburg : Universität, 2024
|
|
Administration
